Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes
Huynh, K., Kiriazis, H., Du, X.-J., Love, J. E., Jandeleit-Dahm, K. A., Forbes, J. M., McMullen, J. R., Ritchie, R. H.
Published in Diabetologia (01.05.2012)
Published in Diabetologia (01.05.2012)
Get full text
Journal Article
The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice
Watson, A. M. D., Li, J., Schumacher, C., de Gasparo, M., Feng, B., Thomas, M. C., Allen, T. J., Cooper, M. E., Jandeleit-Dahm, K. A. M.
Published in Diabetologia (01.01.2010)
Published in Diabetologia (01.01.2010)
Get full text
Journal Article
Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes
Watson, A. M. D., Olukman, M., Koulis, C., Tu, Y., Samijono, D., Yuen, D., Lee, C., Behm, D. J., Cooper, M. E., Jandeleit-Dahm, K. A. M., Calkin, A. C., Allen, T. J.
Published in Diabetologia (01.05.2013)
Published in Diabetologia (01.05.2013)
Get full text
Journal Article
Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice
Watson, A. M. D, Soro-Paavonen, A, Sheehy, K, Li, J, Calkin, A. C, Koitka, A, Rajan, S. N, Brasacchio, D, Allen, T. J, Cooper, M. E, Thomas, M. C, Jandeleit-Dahm, K. J. A
Published in Diabetologia (01.03.2011)
Published in Diabetologia (01.03.2011)
Get full text
Journal Article
Pharmacological inhibition of NOX reduces atherosclerotic lesions, vascular ROS and immune–inflammatory responses in diabetic Apoe−/− mice
Di Marco, E., Gray, S. P., Chew, P., Koulis, C., Ziegler, A., Szyndralewiez, C., Touyz, R. M., Schmidt, H. H. H. W., Cooper, M. E., Slattery, R., Jandeleit-Dahm, K. A.
Published in Diabetologia (01.03.2014)
Published in Diabetologia (01.03.2014)
Get full text
Journal Article
Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes
Koïtka, A, Cao, Z, Koh, P, Watson, A. M. D, Sourris, K. C, Loufrani, L, Soro-Paavonen, A, Walther, T, Woollard, K. J, Jandeleit-Dahm, K. A. M, Cooper, M. E, Allen, T. J
Published in Diabetologia (01.03.2010)
Published in Diabetologia (01.03.2010)
Get full text
Journal Article
Role of Patatin-Like Phospholipase Domain-Containing 3 Gene for Hepatic Lipid Content and Insulin Resistance in Diabetes
Zaharia, Oana P, Strassburger, Klaus, Knebel, Birgit, Kupriyanova, Yuliya, Karusheva, Yanislava, Wolkersdorfer, Martin, Bódis, Kálmán, Markgraf, Daniel F, Burkart, Volker, Hwang, Jong-Hee, Kotzka, Jörg, Al-Hasani, Hadi, Szendroedi, Julia, Roden, Michael
Published in Diabetes care (01.09.2020)
Published in Diabetes care (01.09.2020)
Get full text
Journal Article
HMG-CoA reductase inhibitor rosuvastatin and the angiotensin receptor antagonist candesartan attenuate atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes via effects on advanced glycation, oxidative stress and inflammation
Calkin, A. C, Giunti, S, Sheehy, K. J, Chew, C, Boolell, V, Rajaram, Y. S, Cooper, M. E, Jandeleit-Dahm, K. A
Published in Diabetologia (01.09.2008)
Published in Diabetologia (01.09.2008)
Get full text
Journal Article
Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-β in a murine diabetic model of atherosclerosis
Pham, Y, Tu, Y, Wu, T, Allen, T. J, Calkin, A. C, Watson, A. M, Li, J, Jandeleit-Dahm, K. A, Toh, B-H, Cao, Z, Cooper, M. E, Chai, Z
Published in Diabetologia (2010)
Published in Diabetologia (2010)
Get full text
Journal Article
Plasminogen activator inhibitor-1 production is pathogenetic in experimental murine diabetic renal disease
Lassila, M, Fukami, K, Jandeleit-Dahm, K, Semple, T, Carmeliet, P, Cooper, M. E, Kitching, A. R
Published in Diabetologia (01.06.2007)
Published in Diabetologia (01.06.2007)
Get full text
Journal Article
Large artery biomechanics and diastolic dysfunctionin patients with Type 2 diabetes
Soldatos, G., Jandeleit-Dahm, K., Thomson, H., Formosa, M., D'orsa, K., Calkin, A. C., Cooper, M. E., Ahimastos, A. A., Kingwell, B. A.
Published in Diabetic medicine (01.01.2011)
Published in Diabetic medicine (01.01.2011)
Get full text
Journal Article
Reduced plaque formation induced by rosiglitazone in an STZ-diabetes mouse model of atherosclerosis is associated with downregulation of adhesion molecules
Tikellis, C, Jandeleit-Dahm, K.A, Sheehy, K, Murphy, A, Chin-Dusting, J, Kling, D, Sebokova, E, Cooper, M.E, Mizrahi, J, Woollard, K.J
Published in Atherosclerosis (01.07.2008)
Published in Atherosclerosis (01.07.2008)
Get full text
Journal Article
Early changes in hepatic energy metabolism and lipid content in recent-onset type 1 and 2 diabetes mellitus
Kupriyanova, Yuliya, Zaharia, Oana Patricia, Bobrov, Pavel, Karusheva, Yanislava, Burkart, Volker, Szendroedi, Julia, Hwang, Jong-Hee, Roden, Michael, Roden, M., Al-Hasani, H., Burkart, V., Buyken, A.E., Geerling, G., Hwang, J.H., Herder, C., Icks, A., Jandeleit-Dahm, K., Kahl, S., Kotzka, J., Kuss, O., Lammert, E., Trenkamp, S., Rathmann, W., Szendroedi, J., Ziegler, D.
Published in Journal of hepatology (01.05.2021)
Published in Journal of hepatology (01.05.2021)
Get full text
Journal Article
PPARs and Diabetes-Associated Atherosclerosis
Calkin, A C, Jandeleit-Dahm, K A, Sebekova, E, Allen, T J, Mizrahi, J, Cooper, M E, Tikellis, C
Published in Current pharmaceutical design (01.09.2007)
Published in Current pharmaceutical design (01.09.2007)
Get full text
Journal Article